GSK Plc won US approval for its drug to treat a deadly lung disease, ramping up competition with rival Sanofi.

GlaxoSmithKline Pharmaceuticals (GSK Pharma), Ajanta Pharma, Gland Pharma, Jubilant Pharmova, Torrent Pharmaceuticals, Natco Pharma, Aurobindo Pharma, Lupin, Ipca Labs, Dr Reddy’s Laboratories, Cipla, ...

GSK said combinations of its blood-cancer treatment, Blenrep, have been approved by Japan’s Ministry of Health, and that it expects more approvals through the year. The U.K. pharma company said ...

A fire incident at a contract manufacturing facility of GlaxoSmithKline Pharmaceuticals Ltd (GSK Pharma) has led to a temporary disruption in production. The company is assessing the impact and ...

Citing new information from British drugmaker GSK, U.S. lawmakers are pushing forward with a probe into a pandemic-era political controversy centered around the timing of trial results for Pfizer ...

The FDA has lifted its 19-month clinical hold on vaginal yeast infection drug Brexafemme (ibrexafungerp), according to the treatment's developer Scynexis. In its first-quarter report, the Jersey ...

GSK plc GSK announced that it has signed an agreement with Massachusetts-based biopharmaceutical company Boston Pharmaceuticals to acquire the latter’s lead pipeline drug, efimosfermin alfa ...

GSK Plc agreed to buy an experimental medicine to treat liver disease for as much as $2 billion as the UK drugmaker seeks to shore up its pipeline of new medicines. The treatment developed by Boston ...

GSK will buy efimosfermin, a liver disease drug in late-stage trials, for up to $2 billion from U.S. biotechnology firm Boston Pharmaceuticals, the British drugmaker said on Wednesday. Efimosfermin, a ...

GSK GSK-0.07%decrease; red down pointing triangle will acquire a liver-disease treatment from Boston Pharmaceuticals for up to $2 billion as it seeks to boost its pipeline of new drugs. The ...